Insider Transactions in Q1 2023 at View Ray, Inc. (VRAY)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2023
|
James F. Dempsey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+13.82%
|
$0
$0.75 P/Share
|
|
Mar 03
2023
|
James F. Dempsey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
42,000
-6.03%
|
$168,000
$4.13 P/Share
|
|
Mar 03
2023
|
James F. Dempsey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,000
+5.69%
|
$0
$0.75 P/Share
|
|
Mar 02
2023
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,700
-5.72%
|
$158,800
$4.12 P/Share
|
|
Mar 02
2023
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,100
-4.31%
|
$72,400
$4.25 P/Share
|
|
Mar 02
2023
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
37,493
-7.09%
|
$149,972
$4.25 P/Share
|
|
Mar 02
2023
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37,321
-0.9%
|
$149,284
$4.25 P/Share
|
|
Mar 01
2023
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,502
-2.4%
|
$138,008
$4.12 P/Share
|
|
Mar 01
2023
|
James F. Dempsey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,405
+10.6%
|
-
|
|
Mar 01
2023
|
William P. Burke Mr. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,686
+22.54%
|
-
|
|
Mar 01
2023
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,203
-3.19%
|
$112,812
$4.34 P/Share
|
|
Mar 01
2023
|
Paul Ziegler Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,207
+20.44%
|
-
|
|
Mar 01
2023
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
29,870
-2.71%
|
$119,480
$4.34 P/Share
|
|
Mar 01
2023
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
86,405
+13.4%
|
-
|
|
Mar 01
2023
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
154,948
-1.81%
|
$619,792
$4.34 P/Share
|
|
Mar 01
2023
|
Scott William Drake Director |
BUY
Grant, award, or other acquisition
|
Direct |
483,870
+10.1%
|
-
|
|
Jan 16
2023
|
William P. Burke Mr. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
252,632
+50.0%
|
-
|
|
Jan 03
2023
|
Daniel Jeffrey Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,363
+6.93%
|
$105,452
$4.4 P/Share
|
|
Jan 03
2023
|
Gail R Wilensky Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,727
+5.7%
|
$50,908
$4.4 P/Share
|
|
Jan 03
2023
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
96,546
-2.46%
|
$386,184
$4.4 P/Share
|
|
Jan 03
2023
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,590
+1.81%
|
$66,360
$4.4 P/Share
|
|
Jan 03
2023
|
Susan C Schnabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,909
+5.08%
|
$43,636
$4.4 P/Share
|
|
Jan 03
2023
|
Phillip M Spencer Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,727
+7.59%
|
$50,908
$4.4 P/Share
|